Risk factors for multi-drug resistant tuberculosis in patients at tertiary care hospital, Peshawar.

作者: Rukhsana Anwar , Saadia Ashraf , Naveed Khan , Mukhtiar Zaman Afridi , Fazli Wahab

DOI:

关键词: Cross-sectional studyInternal medicineMulti-drug-resistant tuberculosisHistory of tuberculosisTuberculosisOutpatient clinicPediatricsPulmonologyMedicineFamily historyRifampicin

摘要: Objective To determine the frequency of common risk factors for multi-drug resistant tuberculosis in patients presented at a tertiary care hospital, Peshawar. Study design Cross-sectional, observational study. Place and duration study Pulmonology Department, Khyber Teaching Hospital, Peshawar, from December 2006 to October 2007. Methodology Patients with positive AFB culture sensitivity results found both rifampicin isoniazid or resistance other first line anti-tuberculosis drugs, were recruited Ward Outpatient Department (OPD). Informed verbal consent was taken questionnaire administered all participants Information regarding demographics, education status, occupation, monthly household income, C/S, details past history family TB Multi-Drug Resistant (MDR-TB) recorded. Data analyzed on SPSS version 11. Results A total 30 MDR-TB interviewed. Male (n=17) female (n=13) ratio 1.3:1. Mean age 34.2+/-15.3 years. Ninety-two percent 52.9% male uneducated. In 56.7%, income less than 5,000 rupees 40% between 5,000-10,000 rupees. All had previous Antituberculous Treatment (ATT), which 20% undertaken ATT course once, 53.3% twice 26.7% thrice past. group, 13 (43.3%) not completed their 11 them receiving general practitioner (GP) that time. Seven (23.3%) but no one documented family. Resistance RH present patients; moreover, 56.7% RHEZ+S. Conclusion The most group tuberculosis, repeated courses ATT, prescribed by different clinicians unsupervised treatment GP during initial ATT.

参考文章(17)
A. Sloutsky, M. C. Becerra, J. Bayona, J. Y. Kim, B. Werner, S. S. Shin, P. E. Farmer, M. E. Wilson, J. Freeman, J. J. Furin, R. Timperi, M. Pagano, Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease. ,vol. 4, pp. 108- 114 ,(2000)
Ti T, Kluge Hh, Wright A, Lwin T, Aziz Ma, Noe P, Maung W, Mar Tt, Paramasivan Cn, Htun A, National anti-tuberculosis drug resistance survey, 2002, in Myanmar. International Journal of Tuberculosis and Lung Disease. ,vol. 10, pp. 1111- 1116 ,(2006)
Nikolai Menner, Ingo Günther, Helmut Orawa, Andreas Roth, Indal Rambajan, Jutta Wagner, Helmut Hahn, Shamdeo Persaud, Ralf Ignatius, High frequency of multidrug-resistant Mycobacterium tuberculosis isolates in Georgetown Guyana. Tropical Medicine & International Health. ,vol. 10, pp. 1215- 1218 ,(2005) , 10.1111/J.1365-3156.2005.01521.X
L Rigouts, I Bastian, F Portaels, A Van Deun, Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: are any modifications required? Bulletin of The World Health Organization. ,vol. 78, pp. 238- 251 ,(2000) , 10.1590/S0042-96862000000200014
Ivan Bastian, Robert Colebunders, Treatment and prevention of multidrug-resistant tuberculosis Drugs. ,vol. 58, pp. 633- 661 ,(1999) , 10.2165/00003495-199958040-00005
Afranio L. Kritski, Luis Sergio Rodrigues de Jesus, Eduardo Werneck-Barroso, Maria Armanda Monteiro S. Vieira, Monica K. Andrade, Luis Sergio Rodrigues de Jesus, Eduardo Werneck-Barroso, Maria Armanda Monteiro S. Vieira, Monica K. Andrade, Alice Haffner, Lee W. Riley, Retreatment Tuberculosis Cases Chest. ,vol. 111, pp. 1162- 1167 ,(1997) , 10.1378/CHEST.111.5.1162
M Ruddy, Y Balabanova, C Graham, I Fedorin, N Malomanova, E Elisarova, S Kuznetznov, G Gusarova, S Zakharova, A Melentyev, E Krukova, V Golishevskaya, V Erokhin, I Dorozhkova, F Drobniewski, Rates of Drug Resistance and Risk Factor Analysis in Civilian and Prison Patients With Tuberculosis in Samara Region, Russia Thorax. ,vol. 60, pp. 130- 135 ,(2005) , 10.1136/THX.2004.026922
C. Dye, B. G. Williams, Criteria for the control of drug-resistant tuberculosis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 8180- 8185 ,(2000) , 10.1073/PNAS.140102797